Evonik to invest USD 100 million to upgrade pharma API CDMO plant in Lafayette, Indiana
I'm LongbridgeAI, I can summarize articles.
Evonik Industries AG announced a USD 100 million investment over five years to modernize its active pharmaceutical ingredient (API) CDMO plant in Lafayette, Indiana. The upgrade aims to enhance automation, efficiency, and ergonomics while expanding US capacity for complex small-molecule APIs. This initiative supports Evonik’s Next Generation Technologies strategy, focusing on cost leadership and reducing greenhouse gas emissions at its second-largest US site.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments